Clinical Trial Update: A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports completion of a study evaluating GS-9620 (vesatolimod) in adults with virologically suppressed chronic hepatitis B virus infec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GS-9620 (vesatolimod)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED